Patents by Inventor Tilmann Achsel

Tilmann Achsel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF ARALAR FOR TREATING NEUROLOGICAL DISORDERS
    Publication number: 20240139205
    Abstract: The present invention relates to compounds or pharmaceutical compositions for treating neurological disorders. In particular, the invention relates to a modulator of gamma-Aminobutyric acid (GABA) signaling for use in treating a neurological disorder in a subject with Cyfip1 haploinsufficiency. Furthermore, the present invention relates to a modulator of Aralar for use in treating a neurological disorder. The invention further relates to non-medical uses of the compounds or compositions of the invention. Furthermore, the invention relates to a method for identifying a modulator of Aralar and/or a neuroactive drug.
    Type: Application
    Filed: March 5, 2021
    Publication date: May 2, 2024
    Inventors: Claudia BAGNI, Tilmann ACHSEL, Alexandros KANELLOPOULOS
  • Inducible small RNA expression constructs for targeted gene silencing
    Patent number: 8470797
    Abstract: The invention relates to vectors for the inducible expression of RNA molecules in eukaryotic, particularly mammalian cells and transgenic animals.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: June 25, 2013
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Thomas Tuschl, Tilmann Achsel, Reinhard Luehrmann, Jutta Myer
  • INDUCIBLE SMALL RNA EXPRESSION CONSTRUCTS FOR TARGETED GENE SILENCING
    Publication number: 20120255045
    Abstract: The invention relates to vectors for the inducible expression of RNA molecules in eukaryotic, particularly mam
    Type: Application
    Filed: April 3, 2012
    Publication date: October 4, 2012
    Applicant: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Thomas Tuschl, Tilmann Achsel, Reinhard Lührmann, Jutta Meyer
  • Inducible small RNA expression constructs for targeted gene silencing
    Patent number: 8198077
    Abstract: The invention relates to vectors for the inducible expression of RNA molecules in eukaryotic, particularly mammalian cells and transgenic animals.
    Type: Grant
    Filed: January 15, 2004
    Date of Patent: June 12, 2012
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Thomas Tuschl, Tilmann Achsel, Reinhard Lührmann, Jutta Meyer
  • Inducible small rna expression constructs for targeted gene silencing
    Publication number: 20060212950
    Abstract: The invention relates to vectors for the inducible expression of RNA molecules in eukaryotic, particularly mammalian cells and transgenic animals.
    Type: Application
    Filed: January 15, 2004
    Publication date: September 21, 2006
    Applicant: Max-Planck-Gesellschaft Zur Forderung Der Wisseneschaften E.V.
    Inventors: Thomas Tuschl, Tilmann Achsel, Reinhard Luhrmann, Jutta Meyer
  • Test system for detecting a splicing reaction and use thereof
    Patent number: 6579681
    Abstract: The present invention relates to a test system comprising (a) one or more identical or different immobilized nucleic acid(s) having at least one spliceable nucleic acid, (b) at least one gel-free detection system for detecting a splicing reaction, where appropriate (c) at least one composition comprising splicing components, and preferably (d) suitable detection probes, and, where appropriate, (e) further aids.
    Type: Grant
    Filed: November 27, 2001
    Date of Patent: June 17, 2003
    Assignee: Aventis Research and Technologies GmbH & Co. KG
    Inventors: Christoph Hüls, Bettina Bauer, Claus Simandi, Reinhard Lührmann, Tilmann Achsel, Hans-Peter Vornlocher